Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.

Profiling of circulating microRNAs in children with recent onset of type 1 diabetes.

Erener S, Marwaha A, Tan R, Panagiotopoulos C, Kieffer TJ.

JCI Insight. 2017 Feb 23;2(4):e89656. doi: 10.1172/jci.insight.89656.

2.

Circulating levels of microRNA from children with newly diagnosed type 1 diabetes and healthy controls: evidence that miR-25 associates to residual beta-cell function and glycaemic control during disease progression.

Nielsen LB, Wang C, Sørensen K, Bang-Berthelsen CH, Hansen L, Andersen ML, Hougaard P, Juul A, Zhang CY, Pociot F, Mortensen HB.

Exp Diabetes Res. 2012;2012:896362. doi: 10.1155/2012/896362. Epub 2012 Jul 5. Erratum in: Exp Diabetes Res. 2012;2012:672865.

3.

miR-487a-3p upregulated in type 1 diabetes targets CTLA4 and FOXO3.

Zurawek M, Dzikiewicz-Krawczyk A, Izykowska K, Ziolkowska-Suchanek I, Skowronska B, Czainska M, Podralska M, Fichna P, Przybylski G, Fichna M, Nowak J.

Diabetes Res Clin Pract. 2018 Aug;142:146-153. doi: 10.1016/j.diabres.2018.05.044. Epub 2018 May 31.

PMID:
29859273
4.

Dysregulated Serum MiRNA Profile and Promising Biomarkers in Dengue-infected Patients.

Ouyang X, Jiang X, Gu D, Zhang Y, Kong SK, Jiang C, Xie W.

Int J Med Sci. 2016 Feb 18;13(3):195-205. doi: 10.7150/ijms.13996. eCollection 2016.

5.

Circulating miRNA Profiles Associated With Hyperglycemia in Patients With Type 1 Diabetes.

Satake E, Pezzolesi MG, Md Dom ZI, Smiles AM, Niewczas MA, Krolewski AS.

Diabetes. 2018 May;67(5):1013-1023. doi: 10.2337/db17-1207. Epub 2018 Feb 16.

PMID:
29453204
6.

Identifying common and specific microRNAs expressed in peripheral blood mononuclear cell of type 1, type 2, and gestational diabetes mellitus patients.

Collares CV, Evangelista AF, Xavier DJ, Rassi DM, Arns T, Foss-Freitas MC, Foss MC, Puthier D, Sakamoto-Hojo ET, Passos GA, Donadi EA.

BMC Res Notes. 2013 Nov 26;6:491. doi: 10.1186/1756-0500-6-491.

7.

Circulating MiR-16-5p and MiR-19b-3p as Two Novel Potential Biomarkers to Indicate Progression of Gastric Cancer.

Zhang J, Song Y, Zhang C, Zhi X, Fu H, Ma Y, Chen Y, Pan F, Wang K, Ni J, Jin W, He X, Su H, Cui D.

Theranostics. 2015 Apr 5;5(7):733-45. doi: 10.7150/thno.10305. eCollection 2015.

8.

MicroRNA expression profiles and type 1 diabetes mellitus: systematic review and bioinformatic analysis.

Assmann TS, Recamonde-Mendoza M, De Souza BM, Crispim D.

Endocr Connect. 2017 Nov;6(8):773-790. doi: 10.1530/EC-17-0248. Epub 2017 Oct 6.

9.

The clinical significance of downregulation of mir-124-3p, mir-146a-5p, mir-155-5p and mir-335-5p in gastric cancer tumorigenesis.

Li H, Xie S, Liu M, Chen Z, Liu X, Wang L, Li D, Zhou Y.

Int J Oncol. 2014 Jul;45(1):197-208. doi: 10.3892/ijo.2014.2415. Epub 2014 May 6.

PMID:
24805774
10.

MicroRNAs miR-23a-3p, miR-23b-3p, and miR-149-5p Regulate the Expression of Proapoptotic BH3-Only Proteins DP5 and PUMA in Human Pancreatic β-Cells.

Grieco FA, Sebastiani G, Juan-Mateu J, Villate O, Marroqui L, Ladrière L, Tugay K, Regazzi R, Bugliani M, Marchetti P, Dotta F, Eizirik DL.

Diabetes. 2017 Jan;66(1):100-112. doi: 10.2337/db16-0592. Epub 2016 Oct 13.

11.

Circulating MiR-19b-3p, MiR-134-5p and MiR-186-5p are Promising Novel Biomarkers for Early Diagnosis of Acute Myocardial Infarction.

Wang KJ, Zhao X, Liu YZ, Zeng QT, Mao XB, Li SN, Zhang M, Jiang C, Zhou Y, Qian C, Feng KG, Guan HQ, Tang TT, Cheng X, Chen ZJ.

Cell Physiol Biochem. 2016;38(3):1015-29. doi: 10.1159/000443053. Epub 2016 Mar 4.

12.

miRNA-375 a Sensor of Glucotoxicity Is Altered in the Serum of Children with Newly Diagnosed Type 1 Diabetes.

Marchand L, Jalabert A, Meugnier E, Van den Hende K, Fabien N, Nicolino M, Madec AM, Thivolet C, Rome S.

J Diabetes Res. 2016;2016:1869082. doi: 10.1155/2016/1869082. Epub 2016 May 24.

13.

Different levels of serum microRNAs in prostate cancer and benign prostatic hyperplasia: evaluation of potential diagnostic and prognostic role.

Cochetti G, Poli G, Guelfi G, Boni A, Egidi MG, Mearini E.

Onco Targets Ther. 2016 Dec 13;9:7545-7553. doi: 10.2147/OTT.S119027. eCollection 2016.

15.

Dysregulated Serum MicroRNA Expression Profile and Potential Biomarkers in Hepatitis C Virus-infected Patients.

Zhang S, Ouyang X, Jiang X, Gu D, Lin Y, Kong SK, Xie W.

Int J Med Sci. 2015 Jul 16;12(7):590-8. doi: 10.7150/ijms.11525. eCollection 2015.

16.

Clinical evaluation of microRNA expression profiling in non small cell lung cancer.

Markou A, Sourvinou I, Vorkas PA, Yousef GM, Lianidou E.

Lung Cancer. 2013 Sep;81(3):388-96. doi: 10.1016/j.lungcan.2013.05.007. Epub 2013 Jun 10.

PMID:
23756108
17.

Serum microRNA profiles in children with autism.

Mundalil Vasu M, Anitha A, Thanseem I, Suzuki K, Yamada K, Takahashi T, Wakuda T, Iwata K, Tsujii M, Sugiyama T, Mori N.

Mol Autism. 2014 Jul 30;5:40. doi: 10.1186/2040-2392-5-40. eCollection 2014.

18.

Identification of a set of miRNAs differentially expressed in transiently TIA-depleted HeLa cells by genome-wide profiling.

Sánchez-Jiménez C, Carrascoso I, Barrero J, Izquierdo JM.

BMC Mol Biol. 2013 Feb 6;14:4. doi: 10.1186/1471-2199-14-4.

19.

Plasma Exosomal miRNAs in Persons with and without Alzheimer Disease: Altered Expression and Prospects for Biomarkers.

Lugli G, Cohen AM, Bennett DA, Shah RC, Fields CJ, Hernandez AG, Smalheiser NR.

PLoS One. 2015 Oct 1;10(10):e0139233. doi: 10.1371/journal.pone.0139233. eCollection 2015.

20.

Circulating miR-29a and miR-150 correlate with delivered dose during thoracic radiation therapy for non-small cell lung cancer.

Dinh TK, Fendler W, Chałubińska-Fendler J, Acharya SS, O'Leary C, Deraska PV, D'Andrea AD, Chowdhury D, Kozono D.

Radiat Oncol. 2016 Apr 27;11:61. doi: 10.1186/s13014-016-0636-4.

Supplemental Content

Support Center